Exicure, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid Tumors (NCT03684785) | Exicure, Inc. | 2018-12-13 |
| A Study of AST-008 in Healthy Subjects (NCT03086278) | Exicure, Inc. | 2017-10-20 |
Track Exicure, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.